{
  "fullName": "Piyush Gupta",
  "slug": "piyush-gupta",
  "title": "MD",
  "specialty": "Medicine",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 100,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Piyush Gupta is a Singaporean banker and the chief executive officer (CEO) of DBS Group between 2009 and 2025. He is vice-chairman of the Institute of International Finance since 2013, and a board member of Enterprise Singapore since 2024.",
  "aiSummary": "Piyush Gupta is a medicine specialist with an H-index of 100 at Pediatrics education (Member). Has been published in Science, Cell, Nature. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Pediatrics education"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Pediatrics education",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Medicine"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients",
      "journal": "Science",
      "year": 2017,
      "citationCount": 4402,
      "doi": "10.1126/science.aan4236",
      "sourceUrl": "https://doi.org/10.1126/science.aan4236",
      "verified": true
    },
    {
      "title": "Genomic Classification of Cutaneous Melanoma",
      "journal": "Cell",
      "year": 2015,
      "citationCount": 3164,
      "doi": "10.1016/j.cell.2015.05.044",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2015.05.044",
      "verified": true
    },
    {
      "title": "A Landscape of Driver Mutations in Melanoma",
      "journal": "Cell",
      "year": 2012,
      "citationCount": 2575,
      "doi": "10.1016/j.cell.2012.06.024",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2012.06.024",
      "verified": true
    },
    {
      "title": "B cells and tertiary lymphoid structures promote immunotherapy response",
      "journal": "Nature",
      "year": 2020,
      "citationCount": 2493,
      "doi": "10.1038/s41586-019-1922-8",
      "sourceUrl": "https://doi.org/10.1038/s41586-019-1922-8",
      "verified": true
    },
    {
      "title": "Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy",
      "journal": "Cancer Discovery",
      "year": 2015,
      "citationCount": 1488,
      "doi": "10.1158/2159-8290.cd-15-0283",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-15-0283",
      "verified": true
    },
    {
      "title": "Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 1313,
      "doi": "10.1056/nejmoa1904059",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1904059",
      "verified": true
    },
    {
      "title": "An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer",
      "journal": "Cancer Research",
      "year": 2008,
      "citationCount": 1033,
      "doi": "10.1158/0008-5472.can-07-6854",
      "sourceUrl": "https://doi.org/10.1158/0008-5472.can-07-6854",
      "verified": true
    },
    {
      "title": "Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade",
      "journal": "Cancer Discovery",
      "year": 2016,
      "citationCount": 971,
      "doi": "10.1158/2159-8290.cd-15-1545",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-15-1545",
      "verified": true
    },
    {
      "title": "Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial",
      "journal": "The Lancet Oncology",
      "year": 2012,
      "citationCount": 900,
      "doi": "10.1016/s1470-2045(12)70431-x",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(12)70431-x",
      "verified": true
    },
    {
      "title": "Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance",
      "journal": "Science Translational Medicine",
      "year": 2017,
      "citationCount": 899,
      "doi": "10.1126/scitranslmed.aah3560",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.aah3560",
      "verified": true
    },
    {
      "title": "Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab",
      "journal": "Annals of Oncology",
      "year": 2016,
      "citationCount": 809,
      "doi": "10.1093/annonc/mdw443",
      "sourceUrl": "https://doi.org/10.1093/annonc/mdw443",
      "verified": true
    },
    {
      "title": "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response",
      "journal": "Science",
      "year": 2021,
      "citationCount": 799,
      "doi": "10.1126/science.aaz7015",
      "sourceUrl": "https://doi.org/10.1126/science.aaz7015",
      "verified": true
    },
    {
      "title": "Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma",
      "journal": "Nature Medicine",
      "year": 2018,
      "citationCount": 797,
      "doi": "10.1038/s41591-018-0197-1",
      "sourceUrl": "https://doi.org/10.1038/s41591-018-0197-1",
      "verified": true
    },
    {
      "title": "Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial",
      "journal": "The Lancet Oncology",
      "year": 2017,
      "citationCount": 756,
      "doi": "10.1016/s1470-2045(17)30429-1",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(17)30429-1",
      "verified": true
    },
    {
      "title": "<i>NRAS</i> mutation status is an independent prognostic factor in metastatic melanoma",
      "journal": "Cancer",
      "year": 2011,
      "citationCount": 680,
      "doi": "10.1002/cncr.26724",
      "sourceUrl": "https://doi.org/10.1002/cncr.26724",
      "verified": true
    },
    {
      "title": "Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis",
      "journal": "The Lancet Oncology",
      "year": 2018,
      "citationCount": 647,
      "doi": "10.1016/s1470-2045(18)30078-0",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(18)30078-0",
      "verified": true
    },
    {
      "title": "Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy",
      "journal": "Cell Metabolism",
      "year": 2018,
      "citationCount": 600,
      "doi": "10.1016/j.cmet.2018.02.024",
      "sourceUrl": "https://doi.org/10.1016/j.cmet.2018.02.024",
      "verified": true
    },
    {
      "title": "Prognostic factors for survival in melanoma patients with brain metastases",
      "journal": "Cancer",
      "year": 2010,
      "citationCount": 539,
      "doi": "10.1002/cncr.25634",
      "sourceUrl": "https://doi.org/10.1002/cncr.25634",
      "verified": true
    },
    {
      "title": "AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer",
      "journal": "DSpace@MIT (Massachusetts Institute of Technology)",
      "year": 2009,
      "citationCount": 534,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2046584993",
      "verified": true
    },
    {
      "title": "Exome sequencing identifies GRIN2A as frequently mutated in melanoma",
      "journal": "Nature Genetics",
      "year": 2011,
      "citationCount": 464,
      "doi": "10.1038/ng.810",
      "sourceUrl": "https://doi.org/10.1038/ng.810",
      "verified": true
    },
    {
      "title": "Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma",
      "journal": "Journal of Clinical Investigation",
      "year": 2014,
      "citationCount": 451,
      "doi": "10.1172/jci70454",
      "sourceUrl": "https://doi.org/10.1172/jci70454",
      "verified": true
    },
    {
      "title": "Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients",
      "journal": "Clinical Cancer Research",
      "year": 2012,
      "citationCount": 424,
      "doi": "10.1158/1078-0432.ccr-12-1177",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-12-1177",
      "verified": true
    },
    {
      "title": "Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials",
      "journal": "Journal of Clinical Oncology",
      "year": 2015,
      "citationCount": 423,
      "doi": "10.1200/jco.2014.60.4165",
      "sourceUrl": "https://doi.org/10.1200/jco.2014.60.4165",
      "verified": true
    },
    {
      "title": "Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)",
      "journal": "Nature Medicine",
      "year": 2021,
      "citationCount": 408,
      "doi": "10.1038/s41591-020-01188-3",
      "sourceUrl": "https://doi.org/10.1038/s41591-020-01188-3",
      "verified": true
    },
    {
      "title": "Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade",
      "journal": "Nature Medicine",
      "year": 2021,
      "citationCount": 387,
      "doi": "10.1038/s41591-021-01406-6",
      "sourceUrl": "https://doi.org/10.1038/s41591-021-01406-6",
      "verified": true
    },
    {
      "title": "BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice",
      "journal": "Clinical Cancer Research",
      "year": 2012,
      "citationCount": 375,
      "doi": "10.1158/1078-0432.ccr-12-1626",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-12-1626",
      "verified": true
    },
    {
      "title": "Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations",
      "journal": "Clinical Cancer Research",
      "year": 2018,
      "citationCount": 347,
      "doi": "10.1158/1078-0432.ccr-18-1116",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-18-1116",
      "verified": true
    },
    {
      "title": "The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells",
      "journal": "Oncogene",
      "year": 1999,
      "citationCount": 337,
      "doi": "10.1038/sj.onc.1203183",
      "sourceUrl": "https://doi.org/10.1038/sj.onc.1203183",
      "verified": true
    },
    {
      "title": "Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases",
      "journal": "Cancer Discovery",
      "year": 2019,
      "citationCount": 333,
      "doi": "10.1158/2159-8290.cd-18-1489",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-18-1489",
      "verified": true
    },
    {
      "title": "Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity",
      "journal": "Cancer Cell",
      "year": 2022,
      "citationCount": 312,
      "doi": "10.1016/j.ccell.2022.04.004",
      "sourceUrl": "https://doi.org/10.1016/j.ccell.2022.04.004",
      "verified": true
    },
    {
      "title": "Neoadjuvant relatlimab and nivolumab in resectable melanoma",
      "journal": "Nature",
      "year": 2022,
      "citationCount": 312,
      "doi": "10.1038/s41586-022-05368-8",
      "sourceUrl": "https://doi.org/10.1038/s41586-022-05368-8",
      "verified": true
    },
    {
      "title": "Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials",
      "journal": "The Lancet Oncology",
      "year": 2016,
      "citationCount": 309,
      "doi": "10.1016/s1470-2045(16)30578-2",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(16)30578-2",
      "verified": true
    },
    {
      "title": "Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors",
      "journal": "Journal of Clinical Investigation",
      "year": 2016,
      "citationCount": 298,
      "doi": "10.1172/jci82661",
      "sourceUrl": "https://doi.org/10.1172/jci82661",
      "verified": true
    },
    {
      "title": "Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents",
      "journal": "Clinical Cancer Research",
      "year": 2012,
      "citationCount": 297,
      "doi": "10.1158/1078-0432.ccr-11-1446",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-11-1446",
      "verified": true
    },
    {
      "title": "Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma",
      "journal": "Clinical Cancer Research",
      "year": 2012,
      "citationCount": 296,
      "doi": "10.1158/1078-0432.ccr-12-1632",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-12-1632",
      "verified": true
    },
    {
      "title": "Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature",
      "journal": "Journal for ImmunoTherapy of Cancer",
      "year": 2019,
      "citationCount": 287,
      "doi": "10.1186/s40425-019-0774-y",
      "sourceUrl": "https://doi.org/10.1186/s40425-019-0774-y",
      "verified": true
    },
    {
      "title": "Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial",
      "journal": "The Lancet Oncology",
      "year": 2018,
      "citationCount": 284,
      "doi": "10.1016/s1470-2045(18)30015-9",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(18)30015-9",
      "verified": true
    },
    {
      "title": "Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.",
      "journal": "PubMed",
      "year": 1999,
      "citationCount": 275,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2157191335",
      "verified": true
    },
    {
      "title": "Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition",
      "journal": "Cancer Discovery",
      "year": 2020,
      "citationCount": 275,
      "doi": "10.1158/2159-8290.cd-19-1228",
      "sourceUrl": "https://doi.org/10.1158/2159-8290.cd-19-1228",
      "verified": true
    },
    {
      "title": "A novel AKT3 mutation in melanoma tumours and cell lines",
      "journal": "British Journal of Cancer",
      "year": 2008,
      "citationCount": 267,
      "doi": "10.1038/sj.bjc.6604637",
      "sourceUrl": "https://doi.org/10.1038/sj.bjc.6604637",
      "verified": true
    },
    {
      "title": "Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma",
      "journal": "Annals of Oncology",
      "year": 2018,
      "citationCount": 251,
      "doi": "10.1093/annonc/mdy226",
      "sourceUrl": "https://doi.org/10.1093/annonc/mdy226",
      "verified": true
    },
    {
      "title": "Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma",
      "journal": "Clinical Cancer Research",
      "year": 2009,
      "citationCount": 248,
      "doi": "10.1158/1078-0432.ccr-09-1985",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-09-1985",
      "verified": true
    },
    {
      "title": "A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers",
      "journal": "Clinical Proteomics",
      "year": 2010,
      "citationCount": 243,
      "doi": "10.1007/s12014-010-9055-y",
      "sourceUrl": "https://doi.org/10.1007/s12014-010-9055-y",
      "verified": true
    },
    {
      "title": "The Role of the PI3K-AKT Pathway in Melanoma",
      "journal": "The Cancer Journal",
      "year": 2012,
      "citationCount": 242,
      "doi": "10.1097/ppo.0b013e31824d448c",
      "sourceUrl": "https://doi.org/10.1097/ppo.0b013e31824d448c",
      "verified": true
    },
    {
      "title": "Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.",
      "journal": "PubMed",
      "year": 1998,
      "citationCount": 241,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2113255254",
      "verified": true
    },
    {
      "title": "Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays",
      "journal": "Cancer Cell",
      "year": 2017,
      "citationCount": 231,
      "doi": "10.1016/j.ccell.2017.01.005",
      "sourceUrl": "https://doi.org/10.1016/j.ccell.2017.01.005",
      "verified": true
    },
    {
      "title": "Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in <i>Braf-</i> Mutant Human Cutaneous Melanoma Cells",
      "journal": "Cancer Research",
      "year": 2010,
      "citationCount": 230,
      "doi": "10.1158/0008-5472.can-10-0902",
      "sourceUrl": "https://doi.org/10.1158/0008-5472.can-10-0902",
      "verified": true
    },
    {
      "title": "Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma",
      "journal": "Journal of Molecular Diagnostics",
      "year": 2012,
      "citationCount": 214,
      "doi": "10.1016/j.jmoldx.2012.10.002",
      "sourceUrl": "https://doi.org/10.1016/j.jmoldx.2012.10.002",
      "verified": true
    },
    {
      "title": "Pathways and therapeutic targets in melanoma",
      "journal": "Oncotarget",
      "year": 2014,
      "citationCount": 214,
      "doi": "10.18632/oncotarget.1892",
      "sourceUrl": "https://doi.org/10.18632/oncotarget.1892",
      "verified": true
    },
    {
      "title": "Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium",
      "journal": "The Lancet Oncology",
      "year": 2019,
      "citationCount": 212,
      "doi": "10.1016/s1470-2045(19)30332-8",
      "sourceUrl": "https://doi.org/10.1016/s1470-2045(19)30332-8",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/6/68/1_piyus_gupta_2023.jpg/330px-1_piyus_gupta_2023.jpg",
  "openalexId": "https://openalex.org/A5048327749"
}